Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker
Anastasios I. Birmpilis, A. Paschalis, Apostolis Mourkakis, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1415-1415
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 99
Photodynamic therapy combined with immunotherapy: Recent advances and future research directions
Marta Warszyńska, Paweł Repetowski, J. Dąbrowski
Coordination Chemistry Reviews (2023) Vol. 495, pp. 215350-215350
Open Access | Times Cited: 59
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Identification of Key Biomarkers Associated with Immunogenic Cell Death and Their Regulatory Mechanisms in Severe Acute Pancreatitis Based on WGCNA and Machine Learning
Zhengjian Wang, Jin Liu, Yuting Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3033-3033
Open Access | Times Cited: 36
Immunogenic Cell Death in Hematological Malignancy Therapy
Zhaoyun Liu, Xintong Xu, Kaining Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 13
Open Access | Times Cited: 29
Immunogenic cell death in cancer immunotherapy
Minji Choi, Jisoo Shin, Chae-Eun Lee, et al.
BMB Reports (2023) Vol. 56, Iss. 5, pp. 275-286
Open Access | Times Cited: 23
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 13
Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma
Xin Li, Yu‐Fei Pan, Yibin Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 12
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 12
Erythronecroptosis: an overview of necroptosis or programmed necrosis in red blood cells
Anton Tkachenko, Ondřej Havránek
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3273-3291
Closed Access | Times Cited: 10
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA
Shushan Zhang, Yongquan Huang, Songying Pi, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Targeting the Tumor-Tumor Microenvironment Crosstalk
Sunil Badve, Yesim Gökmen–Polar
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 447-457
Closed Access | Times Cited: 19
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
Jing Liang, Xiaohui Qiao, Luping Qiu, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 19
The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
Nicolò Brandi, Matteo Renzulli
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8598-8598
Open Access | Times Cited: 18
The engineered exosomes targeting ferroptosis: A novel approach to reverse immune checkpoint inhibitors resistance
Anqi Chen, Wenjie Zhang, Chuwen Jiang, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 1, pp. 7-18
Closed Access | Times Cited: 5
Disulfiram/Copper Activates ER Stress to Promote Immunogenic Cell Death of Oral Squamous Cell Carcinoma
Yanjuan Zhao, Bo Zhao, Shujin Zhu
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 1291-1298
Closed Access | Times Cited: 5
Reliable Hallmarks and Biomarkers of Senescent Lymphocytes
Yuliya S. Martyshkina, Valeriy Tereshchenko, Daria A. Bogdanova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15653-15653
Open Access | Times Cited: 12
Guanidine-modified nanoparticles as robust BTZ delivery carriers and activators of immune responses
Xiaodan Xu, Rui Wang, Dongdong Li, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 310-318
Closed Access | Times Cited: 11
Glycerol‐3‐phosphate acyltransferase 3‐mediated lipid droplets accumulation confers chemoresistance of colorectal cancer
Ying Wang, Caihua Xu, Xianfeng Yang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 4
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 4
Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
Yujeong Moon, Hanhee Cho, Kwangmeyung Kim
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 795-795
Open Access | Times Cited: 4
Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
In vitro antitumor and immunomodulatory activities of 1,2,4-oxadiazole derivatives
Héverton Mendes Araújo, Gabriel Acácio de Moura, Yasmim Mendes Rocha, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101950-101950
Open Access
Page 1 - Next Page

Scroll to top